Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

Combining Ivermectin & Mebendazole with Standard Cancer Therapies: Exploring Potential Synergies in the Fight Against Cancer

Courage Against Cancer explores how ivermectin and mebendazole — two promising repurposed drugs — may enhance the effectiveness of standard cancer treatments. Learn how our ovarian cancer preclinical study aims to uncover synergistic potential that could redefine the future of integrative oncology.

Categories
Anti Cancer Cancer Treratments chemotherapy Fenbendazole Ivermectin Mebendazole Natural Treatments preclinical trial

A New Dawn: Courage Against Cancer Funds Its First Preclinical Trial on the Path to FDA Approval

Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.